lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Licochalcone A mitigates
Frontiers Licochalcone A mitigates cisplatin induced nephrotoxicity by inhibiting ferroptosis and mitochondrial dysfunction via the Nrf2 GPX4 axis Bucillamine prevents cisplatin induced ototoxicity through induction of glutathione and antioxidant genes Experimental & Molecular Medicine Full article: Molecular mechanisms of cisplatin resistance in bladder cancer Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



